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Abstract—Parameter calibration is a major challenge in agent-
based modelling and simulation (ABMS). As the complexity of
agent-based models (ABMs) increase, the number of parameters
required to be calibrated grows. This leads to the ABMS
equivalent of the “curse of dimensionality”. We propose an
ABMS framework which facilitates the effective integration of
different sampling methods and surrogate models (SMs) in order
to evaluate how these strategies affect parameter calibration and
exploration. We show that surrogate assisted methods perform
better than the standard sampling methods. In addition, we show
that the XGBoost and Decision Tree SMs are most optimal overall
with regards to our analysis.
Keywords—Agent-based modelling and simulation, surrogate
models, infectious disease epidemiology, machine learning
I. INTRODUCTION
Agent-based models (ABMs) offer the possibility to model
many complex real-world scenarios [1]. These scenarios range
from modelling the spread of an epidemic within a population
to modelling trends based on agents’ behaviour in the stock
market. With the increase in model complexity, the number
of parameters that need to be calibrated, to allow the model
to match real-world data, grows [2]. As a result, searching
for meaningful parameter combinations can become computa-
tionally prohibitive. Machine learning (ML) models, namely
surrogate models (SMs), are capable of effectively searching
the parameter space of ABMs. Previously, SMs have been
used to classify whether a candidate parameter vector is a good
parameter calibration to the ABM to match the real-world data
[3].
In this paper we present the results obtained using our
implementation of the agent-based modelling and simulation
(ABMS) framework shown in Figure 1 to facilitate the pa-
rameterisation challenges of ABMs. In addition, we compare
surrogate assisted sampling methods using different SMs. Our
results obtained show:
• XGBoost and DT SMs perform the best at assisting the
parameterisation of ABMs.
• The surrogate assisted method XGBoost Random is is able
to get within 98.5% of the optimal distribution with the
lowest number of mini-batch evaluations.
• Overall we show that surrogate assisted methods are
more likely to estimate the most optimal parameter vector
which generates a synthetic data distribution that matches
the real data distribution.
• We note the difficulty of calibrating ABMs when one
considers that we are trying to estimate only seven of the
possible nine parameters using synthetic data and raise
the need for further investigation for using real-world
data.
Figure. 1: Agent-based modelling and simulation (ABMS)
framework
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II. BACKGROUND
A. Agent-Based Modelling and Simulation in Epidemiology
Agent-based modelling and simulation (ABMS) is an ef-
fective technique that is a natural fit for modelling infectious
diseases. Agent-based models (ABMs) are capable of mod-
elling interactions between individuals and their environment.
Further, they are capable of capturing unexpected emergent
patterns and trends during an epidemic, which are the result
of combined individual agent behaviours. Each agent within
an ABM is provided with different agent characteristics. The
agents act autonomously, governed by the interaction of their
set of pre-defined rules and distinctive characteristics. As a
result, ABMs require sufficient complexity to model almost
any complex real-world scenario [1]. In addition, ABMS can
be used as a substitute for a real-world epidemiological study
since it is often not feasible or even possible to run a real-
world experiment [4]–[6].
While there are significant benefits to using ABMS for
infectious disease epidemiology, there are equally limitations.
ABMs ordinarily require long run times due to the increased
computational complexity resulting from agent interactions
incorporated into the ABM. Additionally, model validation and
parameterisation present major challenges in ABMS, specifi-
cally in reflecting real-world data. Of these two challenges, we
are particularly interested in the parameterisation of ABMs.
Difficulty with finding correct parameterisations of ABMs
lead to extensive calibration efforts resulting in increased
model development time. As more complexity is added to the
model, the parameter space expands, leading to the ABMS
equivalent of the “curse of dimensionality” problem. The
result is impractical memory and computational costs when
searching for meaningful parameter combinations [2], [3], [5],
[7]–[9].
B. Surrogate Models in Agent-Based Modelling and Simula-
tion
One approach to overcoming the computational limitations
of ABMS is the use of surrogate models (SMs). SMs are
machine learning (ML) models that act as functional approxi-
mations to ABMs. In addition, SMs provide a computationally
tractable solution to addressing the issues of parameter sen-
sitivity analysis, robust analysis and empirical validation in
ABMS. These properties make SMs appealing for approxi-
mating significantly complex ABMs that are computationally
expensive to validate and calibrate [3], [9], [10].
Previously, Gaussian process regression, also known as the
Kriging method, has been used as a surrogate modelling
approach to facilitate parameter space exploration and sen-
sitivity analysis challenges in ABMS. However, Kriging’s
performance is dependent on the model’s ability to estimate
the true spatial continuity of the data [3], [9], [11], [12].
Lamperti, Roventini, and Sani [3] presented an alternate
approach, overcoming some of the limitations of the Kriging
method. An iterative algorithm is proposed for training a SM
to effectively approximate the ABM. The novel approach is
realised by combining ML and intelligent iterative sampling.
It is demonstrated that a model’s parameter space can be
effectively searched utilising fewer computational resources
adopting their approach. In their work the XGBoost non-
parametric ML algorithm is used, where the SM is built in
a stage-wise fashion, allowing optimisation of an arbitrary
differentiable loss function. This method was applied to the
Asset Pricing Model by Brock and Hommes [13] and the
Island Growth model by Fagiolo and Dosi [14]. The results
obtained show that the SM is an accurate functional approx-
imation of the ABM. Further, the SM radically reduced the
computation time for large-scale parameter space calibration
and exploration. Zhang, Li, and Zhang [9] improve on the
work of Lamperti, Roventini, and Sani [3] using the CatBoost
ML algorithm. They show the surrogate is able to approximate
the ABM and as a result further reduce parameter calibration
and exploration time.
C. Quasi-Random Sobol Sampling
Morokoff and Caflisch [15] proposed the Quasi-Random
Sobol sampling strategy, used by Lamperti, Roventini, and
Sani [3] and Zhang, Li, and Zhang [9], which belongs to
the class of Quasi-Monte Carlo methods. In particular, this
approach is ideal when sampling from distributions with an
unknown topology such as the parameter space of ABMs
for infectious diseases. This approach is able to guarantee
uniformity of a distribution by filling up spaces with random
points.
III. METHODOLOGY FOR AGENT-BASED
MODELLING AND SIMULATION
A. Agent-Based Modelling and Simulation Framework
Figure 1 is a representation of our implemented ABMS
framework inspired by the algorithm of Lamperti, Roventini,
and Sani [3]. Our framework starts by selecting the initial
configuration. This includes the sampling method, the ML
algorithm, the values for the ABM MIN Budget and the
ABM MAX Budget limits, a threshold value for the KS test
statistic and the confidence criteria. We generate a pool of
candidate parameter vectors utilising the sampling method.
Subsequently, a mini-batch of these vectors is randomly sam-
pled, where each candidate vector is used as input for the
ABM. The ABM generates synthetic epidemic data based on
the input parameter vector. We compare the similarity between
the distribution of the synthetic epidemic data to the real-
world data using Equation 1 and the corresponding parameter
vector is labelled accordingly. Once we have labelled all of
the parameter vectors from the mini-batch, we subsequently
include these in a ground-truth database. The ground-truth
database contains all the parameter vectors we have evaluated
and labelled. We employ the ground-truth database to construct
an SM using ML techniques and then evaluate if the SM meets
the confidence criteria. We either check if we have reached the
ABM MIN Budget limit or go to Phase 2. After examining
the ABM MIN Budget limit, we either resume at Phase 1
or predict the optimal parameter vector from our database
of labelled vectors. We then verify to see if the predicted
parameter vector’s KS test statistic value is ≤ the set KS
Threshold. Depending on the outcome of the check, we either
evaluate the ABM MAX Budget limit and go to Phase 2 or
stop.
B. Agent-based model
The agent-based model (ABM) used in this framework is
a pre-existing model which has been implemented by the
Julia library, Agents.jl1. The ABM used is a continuous space
virus spread model, where the disease transmission dynamics
follows the basic Susceptible-Infected-Recovered (SIR) frame-
work, proposed by Kermack and McKendrick [16], simulated
for 2000 time-steps. The SIR framework models the ratio
of susceptible, infected and recovered individuals within a
population. Table I contains the true input parameter values
of the ABM that we have considered for parameterisation.
Parameters 1, 2, 3, 6 and 7 are sampled between the range
(0, 1) and parameters 4 and 5 are sampled between the range
(0, 41) days. We have chosen the number 41, which equates to
1000 time steps (half of the total) in our ABM, as our upper
bound to allow the sampling methods to generate candidate
parameter vectors where the Infection Period and Detection
Time are greater than true value.
C. Kolmogorov-Smirnov Test
The two-sample Kolmogorov-Smirnov (KS) test is used to
compare the distributions of the simulated data to the real data
as follows:
DR,S = sup
x
|FR(x)− FS(x)|, (1)
where x represents the feature we are measuring (number
of infected individuals) and FR and FS are the distribution
functions of the real and simulated data respectively [3]. The
KS test requires the cumulative distributions of the samples
being compared to be calculated. The 99% critical value is
used to reject the null hypothesis (two distributions are the
same). The corresponding parameter vector is labelled as
negative if the two distributions are not the same and positive
if the two distributions are similar as seen in Figure 1. In
addition, the data distributions that we are comparing are
time series. The empirical KS test is formulated to assess the
distance between two independent and identically distributed
Table I: Table showing the true values of the considered ABM’s
parameters.
Parameters True Values
1. Transmission Probability (β) 0.639
2. Reinfection Probability 0.129
3. Death Probability 0.44
4. Infection Period 30 days
5. Detection Time 14 days
6. Speed 0.002
7. Interaction Radius 0.012
1https://juliadynamics.github.io/Agents.jl/stable/models/
samples. To use the KS test on our time-series data, we convert
the time-series to a cumulative distribution function by first
performing a cumulative sum along the time dimension. We
then scale the cumulative sum so as to arrive at a cumulative
distribution which maintains the integrity of the time-series.
This makes our problem scale-invariant to the population
size simulated by the ABM, which allows us to measure the
similarity of the exact epidemic trends between the two time-
series distributions.
D. Sampling Methods
1) Random Sampler: This sampling technique is used as
our baseline. We generate N random candidate parameter
vectors. The length of all the candidate parameter vectors
generated are dependent on the number of parameters we are
parameterising.
2) Surrogate Assisted Random Sampler: To improve the
accuracy and efficiency of the random sampler, we propose the
surrogate assisted random sampler. Once we have a confident
SM, we then re-generate a new set of random candidate param-
eter vectors. The new set is passed as input to the SM which
classifies the candidates as positive or negative parameter
calibrations. The parameter pool is then re-initialised using an
-greedy algorithm. We select positively predicted candidates
90% of the time and selecting negatively predicted candidates
10% of the time. This encourages exploration of the parameter
space. This will drive our sampling method to mostly generate
candidate parameters vectors which it classifies as positive
calibrations.
3) Quasi-Random Sobol Sampler: We have used the
Sobol.jl2 package from the Julia library which is based on
the works of Bratley and Fox [17] and Joe and Kuo [18].
This sampling method generates low-discrepancy-sequences of
points that are equally distributed around an N -dimensional
hyper-cube.
4) Surrogate Assisted Quasi-Random Sobol Sampler: In
addition, we propose the surrogate assisted quasi-random sobol
sampler. This sampling method functions in the same way as
the surrogate assisted random sampler. The only difference
between the two methods, other than the SM used, is that one
generates pseudo-random samples and the other quasi-random
sobol samples.
E. Surrogate Models
We evaluated the following machine learning algorithms for
learning surrogate models:
• eXtreme Gradient Boosting (XGBoost): A decision tree
based machine learning algorithm, which is based off the
framework by Friedman [19], that is scalable and efficient
in its implementation [20].
• Decision Tree (DT): A classification algorithm which
works off a tree-like structure, where the nodes represent
a feature/attribute and the branches represent the decision
rule which leads to the outcome of that decision [21].
2https://github.com/stevengj/Sobol.jl
• Support Vector Machine (SVM): A classification al-
gorithm which finds a hyperplane in an N -dimensional
space in order to differentiate between different classes
of data points [22].
The ground-truth database of labelled parameter vectors is
used at each iteration to train a SM. We split the database into
a training and validation set using an 80/20 split. The machine
learning algorithm is trained using the training set and the F1
Score is evaluated on the validation set. The confidence of
the SM, measured by accuracy on the validation set, should
increase as additional examples are stored in the ground-truth
database.
F. Sanity Check
To ensure that our implemented ABMS framework in Figure
1 is reliable, we need to conduct a sanity check. Given a set
of known optimal parameters, θ∗, we use this as input for the
constructed ABM. The ABM will then generate a synthetic
dataset based on the value of θ∗ as output. We subsequently
use the synthetic dataset as the ground truth real-world data
in Figure 1. Thereafter we run through the ABMS framework
and observe if we are able to approximate θ∗.
G. Experiment Setup
1) Initial ABMS Configurations: The following initial con-
figurations are set as: ABM MIN Budget = 500, ABM
MAX Budget = 2500, Batch Size = 50 and KS Threshold
= 0.005 (≈ 99.5% similar to the true distribution). Lastly,
the confidence criteria of the SM is set so that we have at
least evaluated a proportional number of candidate parameter
vectors, dependent on the Batch Size and the number of
parameters we are parameterising, at a validation F1 Score
≥ 0.90. We conducted a total of 56 experiments, averaging
each experiment 10 times, where for each average the true
parameters were varied. We compared all of the sampling
methods implemented, parametersing parameters 1, . . . , 7 as
seen in Table I.
2) Hardware Specifications: The machine used to run our
experiments consisted of an Intel Xeon CPU E5-2683 v4 @
2.10GHz processor with 64 CPUs and 256GB of RAM using
the Ubuntu 18.04.4 LTS operating system.
IV. RESULTS
We evaluate the performance of the various surrogate mod-
els, random sampler and quasi-random sobol sampler in the
context of the following metrics:
• L2 Norm: The euclidean distance between the true input
parameter vectors and the optimal predicted parameter
vectors.
• KS Test Statistic: The maximum distance between two
empirical time-series cumulative distributions functions.
The similarity of the time-series distributions increases as
this value tends to 0.
• Mini-batch Evaluations to Success (BMS): Success is
defined as quality criterion that needs to be achieved i.e.
a solution within 99% or 95% of the known optimal
parameter values. BMS is the number of mini-batches
the framework required to reach success, i.e. the BMS at
a success of 99% would be the number of mini-batches
used to get to within a 99% of the optimal value.
Table II contains standardised the L2 Norm and KS test statis-
tic values for each of the methods that we have implemented,
calibrating parameters 1, . . . , 7. Figure 2 shows the results of
KS test statistic values seen in Table II. The results we have
obtained clearly illustrate that trying to parameterise more than
3 parameters results in a gradual decrease in performance as
measured by the KS test statistic.
The top of Figure 2 shows that Decision Tree Random consis-
tently outperforms Random for parameters 1, 2, 3, 4, 5 and 7.
XGBoost Random outperforms Random for parameters 1, 2,
3 and 7. The bottom of Figure 2 shows for parameterising
parameters 1, . . . , 7, that Decision Tree Sobol outperforms
Sobol for all parameters. The results from Table II and Figure
2 clearly illustrate that XGBoost and DT surrogates are able
to get the lowest KS test statistic values and also the lowest
L2 norm values overall.
Table III contains the averaged minimum number of mini-
batch evaluations it took to reach the optimal predicted pa-
rameter vector. The table also details the number of mini-
batch evaluations to succeed at different percentage intervals
for parameterising 7 of the ABM’s parameters. XGBoost Sobol
is able to reach success at 97% and 97.5% in only 14.3 and
20 mini-batch evaluations on average respectively. XGBoost
Random and SVM Sobol are able to reach success at 98%
and 98.5% respectively in the least amount of mini-batch
evaluations on average. As we scale the problem size and the
complexity of the ABM, we may find that doing so many
mini-batch evaluations is computationally infeasible to reach
Figure. 2: Comparison between the KS test statistic values of
the different sampling methods implemented and the number
of parameters being estimated.
Table II: Standardised L2 Norm and KS test statistic values for the optimal predicted parameter vectors using each of the
sampling methods and surrogate models implemented.
Standardised L2 Norm KS Test Statistic
Parameters 1 2 3 4 5 6 7 1 2 3 4 5 6 7
Random 0.009417 0.092984 0.243392 0.900970 0.738482 1.019350 1.618652 0.001403 0.003458 0.008536 0.026368 0.013968 0.024202 0.020861
XGBoost Random 0.008793 0.079441 0.203277 0.719190 0.971193 1.092223 1.654796 0.000579 0.002841 0.004421 0.030946 0.016041 0.029479 0.017441
DT Random 0.016872 0.076023 0.244910 0.630211 0.934826 1.622811 1.460234 0.000755 0.002326 0.005501 0.021563 0.012496 0.028628 0.022066
SVM Random 0.021645 0.141421 0.259465 0.808132 9.889844 1.139878 1.325837 0.001435 0.003363 0.005310 0.026643 0.013002 0.030652 0.021000
Sobol 0.020650 0.154425 0.229348 0.636288 1.080810 1.073848 1.087858 0.001793 0.003663 0.004975 0.028976 0.015037 0.027414 0.022571
XGBoost Sobol 0.016922 0.083839 0.219330 0.552427 0.877853 1.005900 1.692152 0.001437 0.002350 0.008076 0.027716 0.015726 0.025069 0.023649
DT Sobol 0.014734 0.120076 0.145425 0.689795 0.748668 1.182660 1.397635 0.000956 0.002763 0.004571 0.028165 0.013404 0.021895 0.021317
SVM Sobol 0.013012 0.133107 0.267395 0.695961 0.975068 1.495472 1.118029 0.001650 0.003829 0.007011 0.027626 0.019353 0.027181 0.020611
that level of success.
Table III: Number of mini-batch evaluations on average to
success at (97%, 97.5%, 98% and 98.5%) for estimating 7
ABM parameters.
Mini-batch Evaluations
Sampling Methods 97% 97.5% 98% 98.5%
Random 15.6 25.4 34.4 43.0
XGBoost Random 17.0 25.6 32.9 39.1
DT Random 23.0 26.6 30.2 40.9
SVM Random 22.4 27.3 31.6 40.1
Sobol 20.9 26.8 35.7 40.5
XGBoost Sobol 14.3 20.0 37.2 41.1
DT Sobol 24.5 25.2 29.2 40.5
SVM Sobol 20.5 27.7 27.7 43.1
V. CONCLUSION
We have implemented an ABMS framework which allowed
us to effectively swap out and replace alternative sampling
methods and surrogate models. In addition, the framework
allows us to evaluate the performance of parameter calibration
and exploration challenges in ABMS. To be specific, we
are interested in utilising our approach for infectious disease
epidemiology. Our results demonstrate to us that the surrogate
assisted methods perform much better than the Random and
Quasi-Random Sobol sampling methods. In addition, employ-
ing an XGBoost and DT surrogate is most optimal at assisting
the sampling methods with regards to approximating the real
data distribution. Our future work aims to improve on our
ABMS framework but include different aspects of optimisation
and to evaluate more intelligent sampling methods and ML
algorithms to learn SMs.
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